Sage Prioritizes Zurzuvae For PPD, Ends MDD Effort, Drops Zulresso
Further Strategic Shifts After Recent Cost Cuts
As Sage prioritizes Zurzuvae for postpartum depression after recent setbacks, it will stop selling Zulresso for PPD and no longer pursue Zurzuvae in major depressive disorder.
